Skip to main content
. 2017 Dec 14;9(4):4411–4426. doi: 10.18632/oncotarget.23230

Figure 3. MALAT1 knockdown attenuated the migration of VSMCs.

Figure 3

(A) The cellular migration of VSMCs was evaluated using a wound-healing assay after treatment with MALAT1-specific siRNA. Twenty-four h after transfection with siMALAT1 or control siRNA, the mRNA and protein levels of the migratory markers were subsequently estimated using qRT-PCR (B) and western blotting (C). *P < 0.05; **P < 0.01.